ArticlePharmaceutics2021

The Combination of Tissue-Engineered Blood Vessel Constructs and Parallel Flow Chamber Provides a Potential Alternative to In Vivo Drug Testing Models.

Wanjiku Njoroge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.